急性脑血栓患者经纤溶酶治疗的效果观察

Effect of Fibrinolytic Enzyme in Treatment Patients With Acute Cerebral Thrombosis

目的研究探讨纤溶酶对急性脑血栓的临床治疗效果。方法以我院收治的80例急性脑血栓患者作为研究对象,数字法分为两组,对照组采用巴曲酶治疗,研究组采用纤溶酶治疗,对比两组患者的临床治疗效果。结果研究组的治疗总有效率为85.0%,对照组的治疗总有效率为82.5%,差异不具有统计学意义(P>0.05)。研究组不良反应总发生率为5.0%,低于对照组的12.5%,差异具有统计学意义(P<0.05)。结论纤溶酶与巴曲酶对急性脑血栓的临床治疗效果无差异,但纤溶酶的不良反应率较低,安全性更高。

Objective To investigate the clinical therapeutic effect of fibrinolytic enzyme on acute cerebral thrombosis. Methods To our hospital 80 cases of acute cerebral thrombosis patients as the research object,the digital method divided into two groups. Patients in control group were treated with batroxobin treatment,the study group with fibrinolytic therapy,compared two groups of patients with clinical curative effect. Results The total effective rate was 85% in the study group and 82.5% in the control group,the difference was not statistically significant（P〈0.05）. The incidence rate of adverse reactions in the study group was 5%,lower than that of the control group（12.5%）,and the difference was statistically significant（P〈0.05）. Conclusion There is no difference in clinical treatment of acute cerebral thrombosis,but the adverse reaction rate of the fibrinolytic enzyme is low,and the safety is higher.